logo-small.jpg
Oblato acquires all rights to glioblastoma drug from OMRF
29 oct. 2018 11h21 HE | Oklahoma Medical Research Foundation
OKLAHOMA CITY, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Oblato, Inc., has acquired all rights from the Oklahoma Medical Research Foundation to OKN-007, an investigational drug for the treatment of...
logo-small.jpg
Novel treatment of hemophilia: OMRF enters license agreement with Shanghai RAAS Blood Products
13 févr. 2018 15h02 HE | Oklahoma Medical Research Foundation
OKLAHOMA CITY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- The Oklahoma Medical Research Foundation has entered a license agreement with Shanghai RAAS Blood Products Co., Ltd. Under the agreement, Shanghai...
logo-small.jpg
OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases
24 juil. 2017 11h00 HE | Oklahoma Medical Research Foundation
OKLAHOMA CITY, July 24, 2017 (GLOBE NEWSWIRE) -- The Oklahoma Medical Research Foundation (OMRF) has signed a collaboration agreement with GSK, one of the world’s leading healthcare companies, for...
Eisai, Oklahoma Medical Research Foundation enter autoimmune disease research collaboration
26 oct. 2016 08h00 HE | Oklahoma Medical Research Foundation
WOODCLIFF LAKE, NJ and OKLAHOMA CITY, OK--(Marketwired - October 26, 2016) - Eisai Inc. and the Oklahoma Medical Research Foundation (OMRF) have formed a research collaboration to study the autoimmune...
GtreeBNT Acquires New Drug for the Treatment of Glioblastomas
15 févr. 2016 13h00 HE | Oklahoma Medical Research Foundation;GtreeBNT
PRINCETON, NJ, and OKLAHOMA CITY, OK--(Marketwired - February 15, 2016) - GtreeBNT Co., Ltd., has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) to acquire the...
OMRF, Biogen Enter Autoimmune Disease Collaboration
22 oct. 2015 11h55 HE | Oklahoma Medical Research Foundation
OKLAHOMA CITY, OK--(Marketwired - October 22, 2015) - The Oklahoma Medical Research Foundation and Biogen have formed a research collaboration.Under the new agreement, Biogen researchers will work...
OMRF and Progentec Collaborate to Commercialize New Autoimmune Diagnostics
30 sept. 2015 16h06 HE | Oklahoma Medical Research Foundation;Progentec
OKLAHOMA CITY, OK--(Marketwired - September 30, 2015) - Progentec Diagnostics, Inc. and the Oklahoma Medical Research Foundation have entered into a new collaboration to create tools designed to...
VCs, Biotech Execs Converge on Oklahoma City
09 avr. 2015 16h56 HE | Oklahoma Medical Research Foundation
OKLAHOMA CITY, OK--(Marketwired - Apr 9, 2015) - This week, more than 30 leading venture capitalists and biotechnology industry executives spent the day in Oklahoma City. They were there to attend...